The effect of H1 receptor antagonists on peripheral blood mononuclear cells, adenoid cells and primary cell lines
Authors:
Abstract
This study describes the in vitro effect of three H1 receptor antagonists (dexchlorpheniramine, terfenadine and loratadine) on human peripheral blood mononuclear cells (PBMC, n = 30) from allergic patients and healthy individuals. The three H1 receptor antagonists significantly inhibited antigen/mitogen-induced PBMC proliferation in a concentration-dependent manner. Allergen-specific T-cell responses in allergic individuals were similarly inhibited. The effect of the three drugs was also tested in cultures of mononuclear cells derived from adenoid tissue. The growth kinetics were investigated using spontaneously proliferating cell lines to examine whether the inhibition was caused by general toxicity. Three cell lines, HCT 8 (an ileocaecal adenocarcinoma) RPMI 8866 (B-cell line) and 166 A2 (T hybridoma) were tested. Loratadine (< 0.03 microM) and dexchlorpheniramine (< 0.62 microM) altered the kinetics of HCT 8 and RPMI 8866, respectively. When testing RPMI 8866 and 166 A2, the growth-inhibitory effect of terfenadine and loratadine could be neutralized by addition of cell culture filtrate from RPMI 8866 or 166 A2. These culture filtrates are rich in soluble low-affinity IgE receptor (sCD23) and IgE-binding factor (IgEBF), respectively. Our findings show that the antihistamines investigated display some non-convential in vitro anti-allergic properties possibly not related to their interaction with the H1 receptor. In addition, our results suggest: a) The H1 receptor antagonists used differ in their pattern of cell inhibition; b) The inhibitory effect is completely reversible at low drug concentrations.Keywords
This publication has 33 references indexed in Scilit:
- The effect of disodium cromoglycate (DSCG) on in vitro proliferation of CD4+, CD8+, and CD19+ cell populations derived from allergic and healthy donorsAllergy, 1995
- Effects of loratadine on cytosolic Ca2+ levels and leukotriene release: novel mechanisms of action independent of the anti-histamine activityEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Activation of Human Blood Lymphocytes by House Dust Mite Protein and Mycobacterium tuberculosis Purified Protein Derivative: Effects of Interferon-Gamma, lnterleukin-4, Dexamethasone and Cyclosporin AInternational Archives of Allergy and Immunology, 1994
- The Effect of Disodium Cromoglycate on In Vitro Proliferation of Peripheral Blood Mononuclear Cells from Allergic and Healthy DonorsScandinavian Journal of Immunology, 1992
- T-cell development and transmembrane signaling: changing biological responses through an unchanging receptorImmunology Today, 1991
- New H1‐receptor antagonists: clinical pharmacologyClinical & Experimental Allergy, 1990
- The pharmacology and mechanisms of action of histamine H1‐antagonistsClinical & Experimental Allergy, 1990
- Does the clinical experience with non‐sedating H1‐antagonists justify a reassessment of antihistamines in allergy treatment?Clinical & Experimental Allergy, 1990
- Histamine and its antagonists in asthmaJournal of Allergy and Clinical Immunology, 1989
- Macrophage‐Dependent Response of Immune Human T Lymphocytes to PPD In Vitro Influence of HLA‐D HistocompatibilityScandinavian Journal of Immunology, 1977